RN
Renasant Corporation
RNST · NYSE
$40.53 -0.22% (-$0.09)
1M -2.17%
Market Cap $3.70B
P/E Ratio 11.80x
Div. Yield 2.32%
ROE 8.13%
Bulios Fair Price
$24.85
38.7% downside
Current Price
$40.53
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RNST is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
92 /100
Cheap P/B 0.96x
P/E 11.80x
P/S 2.97x
Growth
60 /100
Stable Book val. growth 22.07%
EPS growth 11.14%
Rev. growth 27.85%
Profitability
69 /100
Strong Op. margin 13.79%
Net margin 25.17%
FCF margin N/A
Quality
58 /100
Average Asset turnover 0.05x
ROE 8.13%
ROA 1.16%
Debt
100 /100
Low Current ratio 11.81x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
87 /100
Stable EPS volatility 32.02%
Beta 0.99x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RNST
Online
Sector
Financial Services
Industry
Banks - Regional
CEO
Kevin D. Chapman
Employees
3,000
Headquarters
Tupelo
Upcoming events
27 OCT
Earnings
Upcoming earnings report